LongSOFWSep 2026
Sofwave Medical Ltd.
Arauca's investment hypothesis is that Sofwave should be viewed as a utilisation platform rather than simply an equipment manufacturer. Usage-fee revenue grew 51% and reached a…
SOFW
1 published idea on Sofwave Medical Ltd. across 1 fund — 1 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Sofwave Medical: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Arauca's investment hypothesis is that Sofwave should be viewed as a utilisation platform rather than simply an equipment manufacturer. Usage-fee revenue grew 51% and reached a…